CN Patent

CN118922190A — 用于治疗眼病的组合物及方法

Assigned to Lenz Treatment Operations Co · Expires 2024-11-08 · 2y expired

What this patent protects

本发明是关于用于治疗老花眼、不规则散光及/或屈光不正的组合物及方法，该等组合物包含约0.1％至约4.0％w/v的毒蕈碱激动剂及约0.07％至约0.15％w/v的溴莫尼定。

USPTO Abstract

本发明是关于用于治疗老花眼、不规则散光及/或屈光不正的组合物及方法，该等组合物包含约0.1％至约4.0％w/v的毒蕈碱激动剂及约0.07％至约0.15％w/v的溴莫尼定。

Drugs covered by this patent

Patent Metadata

Patent number
CN118922190A
Jurisdiction
CN
Classification
—
Expires
2024-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Lenz Treatment Operations Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.